TRACON Pharmaceuticals

TRACON Pharmaceuticals

Focuses on developing and commercializing novel targeted therapeutics for cancer.

HQ location
University City, United States
Launch date
Employees
Market cap
$110k
Enterprise value
($8m)
Share price
$0.03 TCON
Authorizing premium user...